Skip to content

Clinical trials

Phase 2 Cholangiocarcinoma trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Phase 2 Country / region: Taiwan Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20141
20153
20161
20171
20193
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Health Research Institutes, Taiwan2
ASLAN Pharmaceuticals1
EMD Serono Research & Development Institute, Inc.1
Hoffmann-La Roche1
Incyte Corporation1
Janssen Research & Development, LLC1
Kaohsiung Medical University Chung-Ho Memorial Hospital1
Merck Sharp & Dohme LLC1
National Cheng-Kung University Hospital1
PCI Biotech AS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma12
Biliary Tract Neoplasms3
Acrocephalosyndactylia2
Carcinoma, Hepatocellular2
Carcinoma, Non-Small-Cell Lung2
Esophageal Neoplasms2
Gallbladder Neoplasms2
Ovarian Neoplasms2
Bile Duct Neoplasms1
Brain Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.